China SXT Pharmaceuticals (SXTC) Assets Average: 2019-2025
- China SXT Pharmaceuticals' Assets Average fell 11.28% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 million, marking a year-over-year decrease of 11.28%. This contributed to the annual value of $22.4 million for FY2025, which is 14.98% down from last year.
- According to the latest figures from Q3 2025, China SXT Pharmaceuticals' Assets Average is $24.0 million, which was down 8.82% from $26.3 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Assets Average registered a high of $29.3 million during Q1 2021, and its lowest value of $18.9 million during Q1 2024.
- Moreover, its 3-year median value for Assets Average was $24.9 million (2023), whereas its average is $24.0 million.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Assets Average decreased by 27.10% in 2024, and later surged by 39.63% in 2025.
- Quarterly analysis of 5 years shows China SXT Pharmaceuticals' Assets Average stood at $28.6 million in 2021, then decreased by 2.60% to $27.9 million in 2022, then dropped by 20.79% to $22.1 million in 2023, then climbed by 22.61% to $27.1 million in 2024, then dropped by 11.28% to $24.0 million in 2025.
- Its Assets Average stands at $24.0 million for Q3 2025, versus $26.3 million for Q1 2025 and $27.1 million for Q3 2024.
